Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. root
  2. HEPCLUDEX (bulévirtide)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

HEPCLUDEX (bulévirtide)

Medicine - Posted on Aug 07 2025
Active substance (DCI)
  • bulévirtide
history (2)
  • 6/11/25

    HEPCLUDEX (bulévirtide) - Hépatite D chez les patients adultes et pédiatriques âgés de 3 ans et plus

    Réévaluation à la demande de la CT / Extension d’indication pédiatrique L'essentiel Avis favorable au remboursement dans le ...
    CAV :
    54321
    icône flèche
  • Economic analysis
    12/16/20

    HEPCLUDEX (bulevirtide)

    Key points Favourable opinion for reimbursement only in the treatment of chronic hepatitis delta virus (HDV) infection in pl...
    CAV :
    54321
    icône flèche
Technical information
ATC code
  • J05AX28
Manufacturer
GILEAD SCIENCES
Presentation

HEPCLUDEX 2 mg, poudre pour solution injectable
30 flacons en verre (CIP : 34009 302 112 8 1)

All our publications
    Drug therapy Liver diseases Paediatrics Virus diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
mVmEbKtCaMTLgjBs